to22s Bio-Systems is engineering the next generation of Supercritical CO₂ Fractionation. We bypass supply chain fragility by upcycling domestic rice-bran into pharmaceutical-grade bioactive constituents.
Standard commercial extractors top out at 35 MPa. We are commissioning a 10,000 PSI (69 MPa) circuit designed to unlock the heavy ferulate esters and triterpene fractions that standard systems leave behind.
By owning the hardware, we move beyond "Work for Charge" bottlenecks. Our vertical integration allows us to produce high-resolution fractions with zero toxic solvent residues, meeting the underserved demand for pharmaceutical-grade botanical standardization.
Upcycling global agricultural waste into precision molecular assets.
Utilizing domestic rice-milling byproducts as an infinite, low-cost feedstock. We convert a $0.50/kg waste stream into a $1,500/kg clinical asset.
Integrated Column Chromatography allows for the selective enrichment of bioactive triterpenes, creating the world's most potent natural Bcl-2 modulators.
Establishing US-based production to secure feedstock sovereignty and bypass the logistical vulnerabilities of overseas pharmaceutical manufacturing.
Our two-track model provides immediate cash flow via high-end dietary supplements while funding long-term oncology pipelines.
Launching a line of "Standardized Oryza Extracts" under DSHEA compliance. Targeted at the aging demographic for prostatic and metabolic support. Low regulatory hurdle, immediate market entry.
Utilizing supplement profits to fund IND-enabling studies for our 3,12-diol lead asset. Transitioning from wellness to precision oncology licensing deals.
"Owning the infrastructure is the difference between a project and a platform."
6 USPTO Provisionals filed covering Lead Assets, Biorefinery Processes, and Multi-Axial Delivery Systems. Structural Moat established.
V7 Engineering audits and technical specs for the 10,000 PSI circuit finalized. ASTM standards for pressure vessel safety verified.
Commencement of the 100L pilot run. Initial fractionation yields target 98%+ purity on Oryzanol derivatives.
Expansion to 5,000L continuous flow extraction. Securing long-term supply agreements with domestic rice-millers.
We are currently reviewing SBA financing and strategic partnerships for the 2026 pilot launch. Connect with the technical team for the full prospectus.